2-(2,3-dicarboxycyclopropyl)glycine has been researched along with Dyskinesia, Drug-Induced in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chadha, A; Dawson, L; Duty, S; Megalou, M | 1 |
1 other study(ies) available for 2-(2,3-dicarboxycyclopropyl)glycine and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
The group II metabotropic glutamate receptor agonist, DCG-IV, alleviates akinesia following intranigral or intraventricular administration in the reserpine-treated rat.
Topics: Animals; Anticonvulsants; Antipsychotic Agents; Cyclopropanes; Dyskinesia, Drug-Induced; Glycine; Injections; Injections, Intraventricular; Male; Motor Activity; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Reserpine; Substantia Nigra | 2000 |